The Strategic Questions Reshaping the CDMO Map
We sit down with Joerg Ahlgrimm, CEO of SK pharmteco, to discuss his career and the changing landscape for outsourcing
False
We sit down with Joerg Ahlgrimm, CEO of SK pharmteco, to discuss his career and the changing landscape for outsourcing
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 7, 2026
1 min read
Catalent’s John Tomtishen discusses his path into cell therapy and the evolving approaches to CMC, manufacturing, and commercialization
September 21, 2026
5 min read
From isotope supply to reimbursement, the practical challenges shaping real-world delivery in oncology
September 1, 2026
7 min read
Chinese biopharma leaders are returning from the West to build a more confident – and innovative – global industry, says Cyagen’s Lance Han
August 18, 2026
10 min read
From collapsing legacy models to the rise of Chinese biotech, industry leaders are being forced to rethink how drugs are developed, funded, and brought to market
False
Affiliations:
Specialties:
Areas of Expertise: